Paratek Pharmaceuticals, Inc. (PRTK)

Description: Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.

---

Keywords: Medicine Biopharmaceutical Clinical Medicine Organ Systems Antibiotics SMS Infection Multiple Sclerosis Acne Hepatotoxins Bacterial Infections Urinary Tract Infection Pneumonia Rosacea Urinary Tract Infections Skin And Skin Structure Infections Anti Acne Preparations Bacterial Pneumonia Skin And Skin Structure Infection Tetracycline Community Acquired Bacterial Pneumonia Omadacycline

---

Home Page: paratekpharma.com

PRTK Technical Analysis

75 Park Plaza
Boston, MA 02116
United States
Phone: 617 807 6600

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)